tiprankstipranks
Trending News
More News >
Charm Care Corporation (JP:6062)
:6062
Japanese Market
Advertisement

Charm Care Corporation (6062) AI Stock Analysis

Compare
1 Followers

Top Page

JP:6062

Charm Care Corporation

(6062)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 4o)
Rating:72Outperform
Price Target:
¥1,313.00
▲(2.66% Upside)
Charm Care Corporation's stock is supported by strong technical indicators and a favorable valuation, suggesting potential upside. However, mixed financial performance, particularly declining revenue growth and negative free cash flow, pose risks. Investors should weigh these factors when considering the stock.
Positive Factors
Operational Efficiency
Operational efficiency and a stable balance sheet indicate effective management and resource utilization, supporting long-term business sustainability.
Stable Balance Sheet
A stable balance sheet with moderate leverage provides financial flexibility and resilience, crucial for navigating industry challenges and investing in growth.
Strong Return on Equity
Strong return on equity indicates efficient capital use, enhancing shareholder value and supporting the company's ability to reinvest in growth opportunities.
Negative Factors
Declining Revenue Growth
Declining revenue growth suggests challenges in market expansion and sales momentum, potentially impacting future profitability and competitive position.
Negative Free Cash Flow
Negative free cash flow highlights liquidity challenges, limiting the company's ability to fund operations and invest in growth without external financing.
Pressure on Profit Margins
Decreasing profit margins indicate cost pressures or pricing challenges, which could erode profitability and hinder the company's ability to sustain competitive advantage.

Charm Care Corporation (6062) vs. iShares MSCI Japan ETF (EWJ)

Charm Care Corporation Business Overview & Revenue Model

Company DescriptionCharm Care Corporation (6062) is a leading provider in the healthcare sector, specializing in innovative medical devices and healthcare solutions aimed at improving patient outcomes. The company focuses on developing advanced technologies for both hospital and home care environments, including monitoring devices, therapeutic equipment, and software solutions that enhance the efficiency and effectiveness of healthcare delivery.
How the Company Makes MoneyCharm Care Corporation generates revenue through multiple streams, primarily from the sale of medical devices and equipment to hospitals and healthcare providers. Additionally, the company offers subscription-based services for its integrated healthcare software solutions, which provide ongoing support and updates. Key revenue streams include direct sales, long-term contracts with healthcare institutions, and partnerships with technology firms that enhance their product offerings. Significant collaborations with healthcare providers and technology companies further boost their market presence and contribute to sustainable earnings.

Charm Care Corporation Financial Statement Overview

Summary
Charm Care Corporation exhibits mixed financial performance. The income statement shows declining revenue growth and profitability pressures, while the balance sheet remains stable with moderate leverage. However, negative free cash flow indicates liquidity challenges.
Income Statement
65
Positive
Charm Care Corporation's income statement shows a decline in revenue growth rate by 5.32% in the latest year, indicating potential challenges in maintaining sales momentum. Gross profit margin and net profit margin have decreased compared to previous years, suggesting pressure on profitability. However, the company maintains a reasonable EBIT and EBITDA margin, reflecting operational efficiency.
Balance Sheet
70
Positive
The balance sheet reveals a stable financial structure with a debt-to-equity ratio of 0.65, indicating moderate leverage. Return on equity remains strong, showcasing effective use of equity capital. The equity ratio is healthy, suggesting a solid capital base. However, the increase in total debt over the years could pose a risk if not managed carefully.
Cash Flow
50
Neutral
Cash flow analysis indicates a significant decline in free cash flow growth, with a negative free cash flow in the latest year. The operating cash flow to net income ratio is positive, but the free cash flow to net income ratio is concerning, highlighting potential liquidity challenges. The company needs to improve cash generation to support future growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue48.56B46.67B47.83B37.89B29.07B22.98B
Gross Profit8.70B7.24B8.31B6.84B4.65B3.95B
EBITDA7.28B5.69B6.31B5.78B5.38B2.85B
Net Income4.26B2.94B4.28B3.21B2.95B1.54B
Balance Sheet
Total Assets52.82B52.41B47.34B43.30B37.36B28.60B
Cash, Cash Equivalents and Short-Term Investments11.17B15.42B12.64B6.81B6.94B5.94B
Total Debt15.15B13.45B10.88B13.16B10.88B8.31B
Total Liabilities33.22B31.73B28.63B28.17B24.90B17.47B
Stockholders Equity19.59B20.68B18.71B15.13B12.46B11.13B
Cash Flow
Free Cash Flow-4.45B-964.00M6.51B-1.62B1.34B124.00M
Operating Cash Flow-2.00B3.73B10.53B496.00M3.95B2.56B
Investing Cash Flow-6.35B-8.51B-1.67B-2.24B-2.86B-3.70B
Financing Cash Flow3.00B1.28B-3.04B1.62B-87.92M1.47B

Charm Care Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1279.00
Price Trends
50DMA
1149.46
Positive
100DMA
1177.99
Positive
200DMA
1205.57
Positive
Market Momentum
MACD
45.84
Negative
RSI
67.60
Neutral
STOCH
85.29
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6062, the sentiment is Positive. The current price of 1279 is above the 20-day moving average (MA) of 1199.00, above the 50-day MA of 1149.46, and above the 200-day MA of 1205.57, indicating a bullish trend. The MACD of 45.84 indicates Negative momentum. The RSI at 67.60 is Neutral, neither overbought nor oversold. The STOCH value of 85.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6062.

Charm Care Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥53.43B11.864.09%1.86%1370.48%
75
Outperform
¥20.65B11.802.47%3.88%0.31%
72
Outperform
¥35.51B12.122.67%0.30%-31.28%
69
Neutral
¥6.84B3.122.71%1.26%562.09%
65
Neutral
¥42.08B11.410.85%15.77%-50.57%
64
Neutral
¥9.13B12.981.60%18.58%-6.30%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6062
Charm Care Corporation
1,285.00
35.61
2.85%
JP:2374
Saint-Care Holding Corp.
1,216.00
496.66
69.04%
JP:6059
Uchiyama Holdings Co., Ltd.
372.00
68.34
22.51%
JP:6197
Solasto Corp.
561.00
116.60
26.24%
JP:7071
Amvis Holdings.Inc.
477.00
-383.30
-44.55%
JP:7133
HYUGA PRIMARY CARE Co.,Ltd.
1,057.00
-147.69
-12.26%

Charm Care Corporation Corporate Events

Charm Care Corporation Shifts Focus to Core Long-Term Care Business
Nov 7, 2025

Charm Care Corporation announced a strategic shift by discontinuing its Real Estate Business to focus on its core Long-Term Care Business, effective from the first quarter of the fiscal year ending June 2026. This change aims to simplify operations, reduce performance fluctuations, and align with the company’s medium-term management plan, which responds to environmental challenges such as rising construction costs and interest rates.

The most recent analyst rating on (JP:6062) stock is a Hold with a Yen1182.00 price target. To see the full list of analyst forecasts on Charm Care Corporation stock, see the JP:6062 Stock Forecast page.

Charm Care Corporation Reports Strong Q1 Financial Results
Nov 7, 2025

Charm Care Corporation reported a strong financial performance for the three months ending September 30, 2025, with significant year-over-year growth in net sales and profits. The company achieved an 11.7% increase in net sales and a 26.5% rise in operating profit compared to the same period last year. This growth reflects the company’s robust market positioning and effective operational strategies, indicating positive implications for stakeholders.

The most recent analyst rating on (JP:6062) stock is a Hold with a Yen1182.00 price target. To see the full list of analyst forecasts on Charm Care Corporation stock, see the JP:6062 Stock Forecast page.

Charm Care Completes Treasury Stock Disposal for Compensation
Oct 24, 2025

Charm Care Corporation has completed the payment procedures for the disposal of 13,000 shares of its treasury stock as restricted stock compensation, as resolved in the Board of Directors meeting on September 25, 2025. This strategic move is aimed at aligning the interests of its directors with those of the company, potentially impacting its governance and stakeholder relationships positively.

The most recent analyst rating on (JP:6062) stock is a Hold with a Yen1186.00 price target. To see the full list of analyst forecasts on Charm Care Corporation stock, see the JP:6062 Stock Forecast page.

Charm Care Corporation Announces Disposal of Treasury Stock for Director Compensation
Sep 25, 2025

Charm Care Corporation has announced the disposal of 13,000 shares of its treasury stock as part of a restricted stock compensation plan for its directors. This move is aimed at aligning the interests of the directors with those of the shareholders and enhancing the company’s medium- to long-term corporate value. The plan involves a structured agreement that restricts the transfer of shares until certain conditions are met, thereby incentivizing directors to contribute to the company’s sustainable growth.

The most recent analyst rating on (JP:6062) stock is a Hold with a Yen1103.00 price target. To see the full list of analyst forecasts on Charm Care Corporation stock, see the JP:6062 Stock Forecast page.

Charm Care Corporation Affirms Independence Amidst Shareholder Influence
Aug 22, 2025

Charm Care Corporation announced its relationship with its controlling shareholder, Ship Healthcare Holdings Inc., which holds significant influence through its subsidiary STK Corporation. Despite this influence, Charm Care maintains its independence in business activities and management decisions. The company has a business alliance with Ship Healthcare, allowing for collaboration and resource sharing, but transactions remain minimal and conducted on standard terms.

The most recent analyst rating on (JP:6062) stock is a Buy with a Yen1471.00 price target. To see the full list of analyst forecasts on Charm Care Corporation stock, see the JP:6062 Stock Forecast page.

Charm Care Corporation Proposes Re-election of Directors
Aug 22, 2025

Charm Care Corporation announced a proposal for the re-election of seven directors at its upcoming 41st Annual Shareholders’ Meeting. This decision is part of the company’s ongoing governance strategy, ensuring continuity in leadership and potentially impacting its strategic direction and stakeholder confidence.

The most recent analyst rating on (JP:6062) stock is a Buy with a Yen1471.00 price target. To see the full list of analyst forecasts on Charm Care Corporation stock, see the JP:6062 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 12, 2025